| Literature DB >> 35130886 |
Giulio Gorgolini1, Alessandro Caterini1, Kristian Efremov1, Lidio Petrungaro1, Fernando De Maio1, Ernesto Ippolito1, Pasquale Farsetti2.
Abstract
BACKGROUND: Treatment of SCFE is still controversial, especially in moderate and severe forms. Dunn osteotomy performed with the Ganz approach became very popular in the last decade, although it is a complicated and challenging surgical procedure with a risk of AVN. The aim of our study was to analyze the current literature verifying the effectiveness of this surgical procedure, with specific attention to the incidence of AVN and other complications. MAIN BODY: A systematic review on the subject was performed according to the PRISMA guidelines. A literature search was performed by searching all published articles about the topic in the databases. The articles were screened for the presence of the following inclusion criteria: patients affected by slipped capital femoral epiphysis (SCFE) surgically treated by Dunn osteotomy using the Ganz surgical approach. All the patients affected by pathologies other than SCFE, treated without surgery or with procedures not including a surgical hip dislocation were excluded. Based on inclusion and exclusion criteria, 23 studies were included in our systematic review. Selected articles were published from 2009 to 2021 and they included 636 overall hips. According to the selected articles, Dunn osteotomy modified by Ganz, performed by an experienced surgeon, allows for anatomical reduction of moderate or severe SCFE with a low incidence of AVN.Entities:
Keywords: Dunn osteotomy; Flip trochanter osteotomy; Ganz surgical approach; SCFE; Slipped capital femoral epiphysis; Surgical hip dislocation
Mesh:
Year: 2022 PMID: 35130886 PMCID: PMC8822629 DOI: 10.1186/s12891-022-05071-9
Source DB: PubMed Journal: BMC Musculoskelet Disord ISSN: 1471-2474 Impact factor: 2.362
Inclusion and exclusion criteria (PICO)
| Inclusion criteria | Exclusion criteria | |
|---|---|---|
| - Patients affected by slipped capital femoral epiphysis (SCFE) | - Patients who did not underwent surgery | |
| - Dunn osteotomy modified by Ganz with surgical hip dislocation approach | - Surgical techniques without hip dislocation - Non-surgical treatment | |
| - Studies reporting patients affected by SCFE treated by Dunn procedure modified by Ganz, including comparative studies with in situ pinning or Imhauser osteotomy | - Not applicable | |
| - Studies reporting clinical and radiographic scores | - Not applicable | |
| - Studies published from 2001 to 2021 | - Studies published prior to 2001 | |
- Clinical Trials - Cohort Studies - Observational Studies - Randomized Control Trials | - Letters - Case reports - Case series < 10 hips | |
| - English | - Other languages |
Fig. 1Flow diagram, describing the number of studies identified, included and excluded with relative reasons
Characteristics, data, results and conclusions of the included studies
| Paper | Number of Hips | Age at surgery (average) | Classification:stable/ unstable | Classification: acute/chronic/acute-on-chronic | Classification: mild/moderate/ severe | Lenght of Follow-Up (average) | Results | Incidence of AVN | Other complications | Conclusions |
|---|---|---|---|---|---|---|---|---|---|---|
| Agashe et al., Indian J Orthop, 2021 [ | 30 | 13.0 y | 19/11 | 6/6/18 | 0/20/10 | 2.1 y | Average HHS: 81.8 | 6.6% | Hip subluxation: 3.3% | Procedure safe, reliable and reproducible; first choice for treatment of moderate and severe SCFE. |
| Passaplan et al., Bone Joint Open, 2020 [ | 18 | 12.9 y | 14/4 | 1/3/14 | 8/8/2 | 9.4 y | Average HHS: 88.7; HOOS: 87.4; MdA: 16.5; UCLA: 8.4; CAM deformity: 22% | 5.5% | Hip subluxation: 5.5%; Implant failure: 5.5%; Heterotopic ossification: 16.7%; Implant removal: 22.2% | Good long-term results with low incidence of AVN and osteoarthritis but frequent revision surgery (FAI and implant removal). Procedure technically demanding. |
| Zuo et al., J Orthop Surg Res, 2020 [ | 21 | 13.2 y | 20/1 | 1/20/0 | 0/0/21 | 2.6 y | Average HHS: 96.7; WOMAC: 95.4 | 0% | Implant failure: 4.8%; | Procedure technically demanding but safe and extremely valuable for restoring hip anatomy and preserving function in severe SCFE. |
| Ebert et al., J Orthop Surg Res, 2019 [ | 15 | 12.9 y | 15/0 | 0/8/7 | 0/0/15 | 3.8 y | Average HHS: 85.7; NHP: 0.91; VAS: 1.6; SDC: 27.8 | 26.7% | Hip subluxation: 13.3%; implant failure caused by AVN: 13.3% | Satisfactory results in most patients but, considering the risk of complications, the procedure is only indicated in severe chronic or acute on chronic SCFE. |
| Davis et al., JPO, 2019 [ | 48 | 13.8 y (stable) 12.5 y (unstable) | 17/31 | 31/17/0 | N/A | 2.9 y (stable), 2.3 y (unstable) | No data are reported regarding the final results except complications | 29.4% (stable), 6.4% (unstable) | Hip subluxation: 17.6% (stable); Heterotopic ossification: 9.7% (unstable), 5.9% (stable); Hardware removal: 12.9% (unstable), 29.4% (stable) | Effective procedure in stable and unstable hips. Complication rate higher in stable hips. Caution in chronic stable SCFE |
| Sikora-Klak et al., JPO, 2019 [ | 14 | 13.1 y | 14/0 | 0/9/5 | 0/?/? | 2.4 y | No data are reported regarding the final results except complications | 28.6% | Significant limb length inequality: 7.1% | In consideration to the high incidence of AVN observed, the authors are against the procedure in stable, moderate or severe SCFE, preferring Imhauser osteotomy (AVN: 0%). |
| Lerch et al., Bone Joint J, 2019 [ | 46 | 13 y | 32/14 | 9/12/27 | 0/0/46 | 9 y | Average HHS: 94; HOOS: 91; MdA: 17; UCLA: 8; WOMAC: 4; CAM deformity: 7.5% | 5% | Heterotopic ossification: 5%; Implant failure: 7.5%; Implant removal: 17.5% | High functional score at long-term follow-up with low rate of AVN observed only in unstable, acute on chronic slip. Secondary impingement deformities can develop and require further surgery. |
| Novais al, Int Orthop, 2019 [ | 27 | 12.6 y | 0/27 | 14/0/13 | 0/0/27 | 2.4 y | Heyman and Herdon outcomes: excellent or good: 67% | 26% | Trochanteric screw breakage: 3.7% | The theoretical advantage of preserving blood supply reducing AVN rate was not observed. However, the authors observed better results in comparison to closed reduction and percutaneous pinning. |
| Masquijo et al., JPO, 2019 [ | 21 | 12 y | 6/15 | 4/4/13 | Mean preoperative value of slip angle: 59.1° | 3.4 y | Average HHS: 76.3 | 28.6% | Superficial infection: 4.8%; Implant removal: 28.6% | Procedure technically demanding with a high rate of complications probably related to the learning curve. AVN more frequent in unstable hip |
| Persinger et al., JPO, 2019 [ | 31 | 12.4 y | 0/31 | 31/0/0 | N/A | 2.4 y | Satisfactory results: 94% | 6.4% | Mild heterotopic ossification: 6.7%; Implant failure: 3.2%; Implant removal: 6.4% | Procedure safe and effective for unstable SCFE. Low incidence of AVN and other complications. No cases of AVN in patients treated < 24 h. |
| Trisolino et al., JPO, 2018 [ | 15 | 13.9 y | 15/0 | 0/0/15 | 0/0/15 | 3.7 y | NAHS (total): 85.4 | 20% | Mild heterotopic ossification: 6.7% | Procedure restored the proximal femoral anatomy but there is a potential risk of AVN in comparison to SCFE treated by in situ fixation. |
| Ziebarth et al., CORR, 2017 [ | 43 | 13 y | 38/5 | 10/18/15 | 10/27/6 | 12 y | Average MdA: 17; Prevalence of limp: 0%; Positive Drehaman sign: 0%. Cumulative survivorship: 93%; Secondary impingement: 13% | 0% | Refixation of the epiphysis: 9.3%; Reosteosyntesis of the greater trochanter: 2.3%; Implant removal: 20.9% | Procedure, when performed correctly, restored hip anatomy and hip function in stable, moderate or severe SCFE. No hips showed AVN or conversion to THA. Secondary impingement may persist in some hips that need further surgery. |
| Elmarghany et al., SICOT J, 2017 [ | 32 | 14 y | 32/0 | 0/32/0 | 0/11/21 | 1.2 y | Average HHS: 96.2; MdA: 16.8; WOMAC: 3.3; Heyman and Herndon outcome: excellent or good 93.7% | 9.3% | Postoperative deep infection: 3.1%; Revision for bad reduction: 3.1% | Procedure restored the normal proximal femoral anatomy, reducing the probability of secondary osteoarthritis and FAI. |
| Abdelazeem et al., Bone Joint J, 2016 [ | 32 | 14.3 y | 32/0 | 0/32/0 | 0/10/22 | 2 y | Average HHS: 96.3; MdA: 16.8; WOMAC: 97 | 3.1% | Postoperative deep infection: 3.1% | Procedure safe and effective for stable SCCFE with high degree of slip. |
| Novais et al., CORR, 2015 [ | 15 | 14 y | 15/0 | N/A | 0/0/15 | 2.4 y | Heyman and Herdon outcomes: excellent/good: 60% | 6.7% | Implant failure: 6.7%; Intraarticular pin penetration: 6.7% | Higher rate of excellent and results, with similar occurrence of complications when compared to SCFE treated by in situ pinning. |
| Upasani et al., JPO, 2014 [ | 43 | 11.9 y | 17/26 | 17/11/15 | 0/6/37 | 2.6 y | No data are reported regarding the final results but high complication rates are reported (> 40%) | 23.2% | Femoral neck nonunion: 9.3%; Postoperative hip dislocation: 4.6%; Heterotopic ossification: 2.3%; Implant failure: 2.3% | Complication rate high. Presence of an expert surgeon during the procedure. AVN more frequent in unstable acute and acute on chronic SCFE (90%). |
| Souder et al., JPO, 2014 [ | 17 | 12.2 y | 10/7 | N/A | N/A | 1.3 y | AVN in 2/10 stable and in 2/7 unstable (Dunn); AVN in 0/64 stable and in 3/7 unstable (in situ pinning) | 23.5% | Condrolysis: 5.9%; Implant failure: 5.9% | Attempts to anatomically reduce stable slips led to severe AVN in 20% of cases. Treatment of unstable slips remains problematic with high AVN rates whether treated by Dunn or in situ pinning. |
| Sankar et al., JBJS Am, 2013 [ | 27 | 12.6 y | 0/27 | 27/0/0 | 0/6/37 | 1.8 y | Average HHS: 88 (no AVN), 60 (AVN); Satisfaction: 97.1% (no AVN), 65.8% (AVN); UCLA: 9.3 (no AVN), 5.9 (AVN) | 25.9% | Implant failure: 14.8% | Procedure is able to restore anatomy and preserve hip function but AVN and implant complications may occur. |
| Madan et al., JBJS Br, 2013 [ | 28 | 12.9 y | 11/17 | 9/11/8 | 0/0/28 | 3.2 y | Average HHS: 89.1; NAHS: 91.3 | 7.1% | Condrolysis: 3.6% | Procedure safe and reliable in patients with SCFE. ROM at final follow-up was nearly normal. |
| Massé et al., Hip Int, 2012 [ | 20 | 14.3 y | 18/2 | N/A | 8/4/8 | 2.0 y | Average HHS: 98.2; WOMAC: 0.6 (pain), 2.2 (function) | 0% | Wire penetration in the hip joint: 5%; painful implant (removal): 5%; | The small number of technical complications appears favorable considering the surgical complexity of the procedure. |
| Huber et al., JBJS Br, 2011 [ | 30 | 12.2 y | 27/3 | 3/?/? | 3/17/10 | 3.8 y | Average HHS: 97.8; WOMAC: 5.9 (pain), 10.4 (stiffness), 5.7 function) | 3.3% | Implant failure: 13.3% | Anatomical reduction can be achieved using this procedure with low risk of AVN. Implant failures may occur. |
| Slongo et al., JBJS Am, 2010 [ | 23 | 11.9 y | 20/3 | 0/9/14 | N/A | 2.4 y | Average HHS: 99; MdA: 17 | 8.7% | Wire penetration in the hip joint: 4.3% | Procedure minimizes secondary femoroacetabular Cam impingement and osteoarthritis. Complication rate low even in unstable SCFE. |
| Ziebarth et al., CORR, 2009 [ | 40 | 11.9 y | 27/13 | 11/29/? | 0/16/19 (no information on 5 hips) | 2.6 y | Average HHS: 99.6; MdA: 17.8; WOMAC: 1.2 (pain), 3 (function) | 0% | Heterotopic ossification: 2.5%; Residual impingement: 2.5%; Delayed union: 7.5%; Implant failure: 7.5%; | Acceptable complication rate. Procedure reproducible for full correction of moderate to severe SCFE with open physis. |
Fig. 2Flow chart of surgical treatment according to clinical and radiographic classifications